
### [MONDO:0020177](http://purl.obolibrary.org/obo/MONDO_0020177)
**Label:** pigmented palpebral tumor

**Subclasses:** [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0008097](http://purl.obolibrary.org/obo/MONDO_0008097) (linear nevus sebaceus syndrome), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0008057](http://purl.obolibrary.org/obo/MONDO_0008057) (Carney complex, type 1), [MONDO:0020178](http://purl.obolibrary.org/obo/MONDO_0020178) (palpebral lentiginosis), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0020179](http://purl.obolibrary.org/obo/MONDO_0020179) (palpebral nevus), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), [MONDO:0011525](http://purl.obolibrary.org/obo/MONDO_0011525) (CNC2), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), 

**Corr. equiv. classes:** [OMIM:608837](http://purl.obolibrary.org/obo/OMIM_608837), [OMIM:160980](http://purl.obolibrary.org/obo/OMIM_160980), [OMIM:155601](http://purl.obolibrary.org/obo/OMIM_155601), [OMIM:155700](http://purl.obolibrary.org/obo/OMIM_155700), [OMIM:151100](http://purl.obolibrary.org/obo/OMIM_151100), [Orphanet:2612](http://www.orpha.net/ORDO/Orphanet_2612), [OMIM:613099](http://purl.obolibrary.org/obo/OMIM_613099), [OMIM:615134](http://purl.obolibrary.org/obo/OMIM_615134), [OMIM:175200](http://purl.obolibrary.org/obo/OMIM_175200), [Orphanet:618](http://www.orpha.net/ORDO/Orphanet_618), [Orphanet:2869](http://www.orpha.net/ORDO/Orphanet_2869), [OMIM:613972](http://purl.obolibrary.org/obo/OMIM_613972), [OMIM:611554](http://purl.obolibrary.org/obo/OMIM_611554), [Orphanet:319340](http://www.orpha.net/ORDO/Orphanet_319340), [OMIM:615848](http://purl.obolibrary.org/obo/OMIM_615848), [OMIM:608035](http://purl.obolibrary.org/obo/OMIM_608035), [OMIM:605244](http://purl.obolibrary.org/obo/OMIM_605244), [OMIM:609048](http://purl.obolibrary.org/obo/OMIM_609048), [OMIM:163200](http://purl.obolibrary.org/obo/OMIM_163200), [Orphanet:500](http://www.orpha.net/ORDO/Orphanet_500), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [Orphanet:98587](http://www.orpha.net/ORDO/Orphanet_98587), [Orphanet:98588](http://www.orpha.net/ORDO/Orphanet_98588), [OMIM:613707](http://purl.obolibrary.org/obo/OMIM_613707), 

**Class expressions from DL-Learner:**

- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 35.24%
- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and (not ([HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system))) 34.50%
- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and (not ([HP:0002814](http://purl.obolibrary.org/obo/HP_0002814) (Abnormality of the lower limb))) 33.20%
- Thing 31.07%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 31.07%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 30.59%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.92%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 28.53%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 27.97%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 27.75%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 21.60%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 21.17%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 20.74%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) 19.47%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 18.59%


